Depreciation in USD of Baudax Bio, Inc. from Q3 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Baudax Bio, Inc. quarterly/annual Depreciation history and change rate from Q3 2018 to Q3 2023.
  • Baudax Bio, Inc. Depreciation for the quarter ending 30 Sep 2023 was $131,000.000, a 1356% increase year-over-year.
  • Baudax Bio, Inc. Depreciation for the twelve months ending 30 Sep 2023 was $148,000.000.
  • Baudax Bio, Inc. annual Depreciation for 2022 was $51,000.000, a 33.8% decline from 2021.
  • Baudax Bio, Inc. annual Depreciation for 2021 was $77,000.000, a 81.1% decline from 2020.
  • Baudax Bio, Inc. annual Depreciation for 2020 was $408,000.000, a 15% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Baudax Bio, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $148,000 $131,000 +$122,000 +13.6% 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2023
Q2 2023 $26,000 $1,000 -$14,000 -93.3% 01 Apr 2023 30 Jun 2023 10-Q 16 Aug 2023
Q1 2023 $40,000 $3,000 -$11,000 -78.6% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $51,000 $13,000 +$131,000 01 Oct 2022 31 Dec 2022 8-K 28 Jun 2023
Q3 2022 -$80,000 $9,000 -$37,000 -80.4% 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023
Q2 2022 -$43,000 $15,000 -$48,000 -76.2% 01 Apr 2022 30 Jun 2022 10-Q 16 Aug 2023
Q1 2022 $5,000 $14,000 -$72,000 -83.7% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $77,000 -$118,000 -$211,000 -2.3% 01 Oct 2021 31 Dec 2021 8-K 28 Jun 2023
Q3 2021 $288,000 $46,000 -$58,000 -55.8% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 $346,000 $63,000 -$43,000 -40.6% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $389,000 $86,000 -$19,000 -18.1% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $408,000 $93,000 -$18,000 -16.2% 01 Oct 2020 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 $426,000 $104,000 -$19,000 -15.4% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $445,000 $106,000 -$17,000 -13.8% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 $462,000 $105,000 -$18,000 -14.6% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 $480,000 $111,000 01 Oct 2019 31 Dec 2019 10-K 16 Feb 2021
Q3 2019 $123,000 -$38,000 -23.6% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $123,000 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $123,000 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020
Q3 2018 $161,000 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019

Baudax Bio, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $51,000 -$26,000 -33.8% 01 Jan 2022 31 Dec 2022 8-K 28 Jun 2023
2021 $77,000 -$331,000 -81.1% 01 Jan 2021 31 Dec 2021 8-K 28 Jun 2023
2020 $408,000 -$72,000 -15% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2022
2019 $480,000 +$84,000 +21.2% 01 Jan 2019 31 Dec 2019 10-K 16 Feb 2021
2018 $396,000 01 Jan 2018 31 Dec 2018 10-K 13 Feb 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.